Clinical Trial Update: Clinical Trial to Optimise Levels of Vitamin D for Rhinovirus Protection [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating whether optimizing vitamin D levels can protect against rhinovirus-induced common cold was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Cold

Drugs mentioned

• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Queen Mary University of London | Conditions: Common Cold | Phase 2 | Status: WITHDRAWN